Marc Symons, PhD, professor in The Feinstein Institute for Medical Research’s Karches Center for Oncology Research, is examining if a common medication administered to treat pinworms, could replace the current treatment used for certain brain cancers. These findings, which are published today in the Feinstein Institute Press’s peer-reviewed, open-access journal Molecular Medicine, could help to...
Post
A New Drug May Be Able to Completely Reverse Diabetes
IN BRIEF Scientists have used a new drug to reverse diabetes in mice. The drug inhibits the enzyme LMPTP, which contributes to the development of Type 2 diabetes by weakening the body’s sensitivity to the hormone. DEFINING DIABETES In the global community, the number of people with diabetes has been on the rise since 1980, with 422...
Post
Link between Streptococcal infections and blood type
Infectious disease scientists at the Illawarra Health and Medical Research Institute (IHMRI) have found that people with a common blood group could be more susceptible to Streptococcal infections. This work has been published in a top-ranking international microbiology publication, mBIO. Streptococcal infection varies from mild sore throats to lethal blood infections or organs. Repeated infections...
Post
Successful sensory cell regeneration raises hope for restoration
St. Jude Children’s Research Hospital investigators regenerated auditory hair cells in adult mice using genetic manipulation. This research provides possible advanced treatment for auditory loss in humans. The leading cause of hearing loss is due to auditory hair cell depletion. It could be caused by a variety of reasons such as loud noise, accidents, illness,...
Post
Gut bacteria compound may help to prevent type 2 diabetes
New research from Finland suggests that higher blood levels of indolepropionic acid – a product of gut bacteria that is increased by a fiber-rich diet – may help to protect against type 2 diabetes. The study suggests that having high blood levels of indolepropionic acid, which is a byproduct of gut bacteria, may protect against...
Post
An alternative to Statins with Stem cell drug screen
Stem cell drug screen yields potential alternative to statins. A novel drug screen in liver-like cells produced from a patient’s stem cells shows that cardiac glycosides could reduce LDL cholesterol differently from statins, report researchers at the Medical University of South Carolina. In a study appearing in the April 6, 2017 issue of Cell Stem...
Post
‘Medicinal food’ diet counters onset of type 1 diabetes
Monash University researchers, Dr. Eliana Mariño and Professor Charles Mackay. Monash University’s Biomedicine Discovery Institute researchers have led an international study that found – for the first time – that a diet yielding high amounts of the short-chain fatty acids acetate and butyrate provided a beneficial effect on the immune system and protected against...
Post
Robotic leg brace to aid paralyzed people walk
Tokyo (AP) – Toyota is launching a wearable robotic leg brace that help partially paralyzed people to walk. The Welwalk WW-1000 system is made up of a motorized mechanical frame that fits on a person’s leg below the knee. Patients can practice walking wearing the robotic device on a special treadmill which supports their weight....
Post
Researchers unravel how stevia controls blood sugar levels
What makes stevia taste so extremely sweet? And how does the sweetener keep our blood sugar level under control? Researchers at KU Leuven (University of Leuven, Belgium) have discovered that stevia stimulates a protein that is essential for our perception of taste and is involved in the release of insulin after a meal. These results...
Post
Researchers find novel way to induce pancreatic cancer cell death
Pancreatic cancer: Pancreatic cancer, most frequently pancreatic ductal adenocarcinoma (PDAC), is the most lethal and aggressive of all cancers. Unfortunately, there are not many effective therapies available other than surgery, and that is not an option for many patients. scientists at Wake Forest Baptist Medical Center in collaboration with those at the University of Texas...